Notably, PGRN showed therapeutic effects in several models of TNF‐mediated inflammatory arthritis, including collagen‐induced arthritis (CIA), collagen antibody–induced arthritis, and spontaneous arthritis in the TNF‐transgenic mouse model 14, 16, 17. The gene discussed is TNF; the disease is arthritic joint disease.